WILLIAM HENSLEY: Open Payments
NPI 1740761147 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,497 in 86 payments from 17 companies in 2025. Trend: 2023 $1,552 · 2024 $1,652 · 2025 $1,497
Food & beverage: $1,497
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 30 | $342 |
| Inspire Medical Systems, Inc. | 13 | $256 |
| GENZYME CORPORATION | 6 | $178 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| HARMONY BIOSCIENCES LLC | 4 | $86 |
| Verona Pharma, Inc. | 4 | $80 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 4 | $59 |
| Baxter Healthcare | 2 | $54 |
| Amgen Inc. | 2 | $38 |
Products named: INSPIRE, DUPIXENT, NUCALA, TEZSPIRE, TRELEGY ELLIPTA, WAKIX, Ohtuvayre, LEQVIO.
Industry payments across KY — which companies pay providers there.
